Treatment with VBC117 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new experimental drug (called VBC117) for people with advanced solid tumors that have spread. The drug is a type of targeted therapy that seeks out cancer cells and delivers a chemotherapy-like payload directly to them. The study aims to find the best dose and see if it is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have an advanced solid tumor that cannot be removed with surgery or has spread.
- You have at least one tumor that can be measured on a scan.
- You are able to take care of yourself (up and about, capable of light work).
- You have a life expectancy of more than 12 weeks.
- You have a tumor tissue sample available or are willing to have a biopsy.
- You have not had certain types of previous cancer treatments (like antibody-drug conjugates with a topoisomerase inhibitor).
- You do not have known or suspected brain metastases or spinal cord compression.
- You do not have any unresolved severe side effects from prior cancer treatments.
- You do not have interstitial lung disease or a history of it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called VBC108 in people with advanced solid tumors that have not responded to other treatments. The study aims to see if the drug is safe and effective.
This Phase 1 trial tests VVD-130037, a new experimental medicine, to see if it is safe and tolerable in people with advanced (metastatic or unresectable) solid cancers. If you have already tried standard treatments and your body can handle study medication, you may be eligible—especially for certain lung, head and neck, or esophageal cancer types with specific genetic changes.
This study tests a new experimental drug called BR113, given as an injection, for people with advanced solid tumor cancers that have stopped responding to standard treatments. The goal is to see if the drug is safe and effective in shrinking or controlling the cancer.
This trial tests new experimental cancer treatments and technologies for people with rare or hard-to-treat tumors. It aims to find tailored therapies that may work better for your specific cancer. You will be asked to provide a tumor sample for testing, and the trial team will guide you through the process.
This trial tests a new drug called VBC101 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if VBC101 is safe and effective.
This trial tests a new drug called VBC106 in people with advanced solid tumors that have grown despite standard treatments. The goal is to see if the drug can shrink tumors or slow their growth.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.